Home / Drugs / Asfotase alfa

Asfotase alfa

FDA Drug Profile

Drug Details

Generic Name
Asfotase alfa
Brand Names
N/A
Application Number
Sponsor
Lonza Biologics Inc.
NDC Codes
1
Dosage Forms
LIQUID
Routes
N/A
Active Ingredients
ASFOTASE ALFA

Indications and Usage

1 INDICATIONS AND USAGE STRENSIQ ® is indicated for the treatment of patients with perinatal/infantile- and juvenile-onset hypophosphatasia (HPP). STRENSIQ is a tissue nonspecific alkaline phosphatase indicated for the treatment of patients with perinatal/infantile- and juvenile-onset hypophosphatasia (HPP). ( 1 )